Precigen (PGEN) Exchange Rate Effect (2013 - 2026)
Precigen (PGEN) posted quarterly Exchange Rate Effect of -$3000.0 for Q1 2026, down 250.0% year-over-year from $2000.0 in Q1 2025, and down 115.0% quarter-over-quarter from $20000.0 in Q4 2025.
Powered by 
Analysis
Precigen (PGEN) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Precigen (PGEN) has reported Exchange Rate Effect for 14 consecutive years, with -$3000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 250.0% year-over-year to -$3000.0; the TTM figure through Mar 2026 stood at $30000.0 (down 14.29% YoY), while the FY2025 annual figure was $35000.0, up 229.63% from the prior year.
- Exchange Rate Effect slipped to -$3000.0 in Q1 2026 per PGEN's latest filing, from $20000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $70000.0 in Q3 2024 and bottomed at -$333000.0 in Q3 2022.
- Historically, Exchange Rate Effect has averaged -$67176.5 across 5 years, with a median of -$23000.0 in 2022.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect tumbled 1990.91% — and 2025, when it surged 1100.0%.
- Precigen's Exchange Rate Effect stood at -$23000.0 in 2022, then jumped by 39.13% to -$14000.0 in 2023, then jumped by 85.71% to -$2000.0 in 2024, then soared by 1100.0% to $20000.0 in 2025, then tumbled by 115.0% to -$3000.0 in 2026.
- Business Quant data shows PGEN's Exchange Rate Effect at -$3000.0 in Q1 2026, $20000.0 in Q4 2025, and $10000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn | 1,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Sep 30, 2024 | 70,000.00 |
| Jun 30, 2024 | -35,000.00 |
| Mar 31, 2024 | -60,000.00 |
| Dec 31, 2023 | -14,000.00 |
| Sep 30, 2023 | -134,000.00 |
| Jun 30, 2023 | -144,000.00 |
| Mar 31, 2023 | -28,000.00 |
| Dec 31, 2022 | -23,000.00 |
| Sep 30, 2022 | -333,000.00 |
| Jun 30, 2022 | -241,000.00 |
| Mar 31, 2022 | -230,000.00 |
| Dec 31, 2021 | -47,000.00 |
| Sep 30, 2021 | 80,000.00 |